Abstract:BACKGROUND:Although a number of clinical and preclinical studies have demonstrated analgesic effects of cannabinoid treatments, there are also instances when cannabinoids have had no effect or even exacerbated pain. The observed pro-nociceptive effects appear to be due to cannabinoid-induced disinhibition of afferent synaptic input to nociceptive circuits. To better understand how cannabinoid-mediated plasticity can have both pro- and anti-nociceptive effects, we examined the possibility that cannabinoids differentially modulate nociceptive vs. non-nociceptive synapses onto a shared postsynaptic target. These experiments were carried out in the central nervous system (CNS) of the medicinal leech, in which it is possible to intracellularly record from presynaptic nociceptive (N-cell) or pressure-sensitive (P-cell) neurons and their shared postsynaptic targets.RESULTS:The endocannabinoid 2-arachidonoyl glycerol (2AG) elicited significant long-lasting depression in nociceptive (N-cell) synapses. However, non-nociceptive (P-cell) synapses were potentiated following 2AG treatment. 2AG-induced potentiation of non-nociceptive synapses was blocked by the TRPV antagonist SB366791, suggesting involvement of the same TRPV-like receptor that has already been shown to mediate endocannabinoid-dependent depression in nociceptive inputs. Treatment with the GABA receptor antagonist bicuculline also blocked 2AG-induced potentiation, consistent with the idea that increased synaptic signaling was the result of endocannabinoid-mediated disinhibition. Interestingly, while bicuculline by itself increased non-nociceptive synaptic transmission, nociceptive synapses were depressed by this GABA receptor antagonist indicating that nociceptive synapses were actually excited by GABAergic input. Consistent with these observations, GABA application depolarized the nociceptive afferent and hyperpolarized the non-nociceptive afferent.CONCLUSIONS:These findings show that endocannabinoids can differentially modulate nociceptive vs. non-nociceptive synapses and that GABAergic regulation of these synapses plays an important role in determining whether endocannabinoids have a potentiating or depressing effect.

A Common Molecular Basis For Exogenous And Endogenous Cannabinoid Potentiation Of Glycine Receptors (April, Pg 5200, 2012)

Cannabinoid Potentiation of Glycine Receptors Contributes to Cannabis-Induced Analgesia.

A millisecond coarse-grained simulation approach to decipher allosteric cannabinoid binding at the glycine receptor α 1

A millisecond coarse-grained simulation approach to decipher allosteric cannabinoid binding at the glycine receptor α1

Involvement of Glycine Receptor Α1 Subunits in Cannabinoid-Induced Analgesia.

Aminomethanesulfonic acid illuminates the boundary between full and partial agonists of the pentameric glycine receptor

Glycine Induces Bidirectional Modifications in N-methyl-D-aspartate Receptor-Mediated Synaptic Responses in Hippocampal CA1 Neurons.

Enhancement of homomeric glycine receptor function by longchain alcohols and anaesthetics

Membrane Cholesterol Dependence of Cannabinoid Modulation of Glycine Receptor

5-HT Potentiates GABA- and Glycine-Activated Chloride Currents on the Same Neurons in Rat Spinal Cord.

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.

Modulation of the Cys-loop Ligand-Gated Ion Channels by Fatty Acid and Cannabinoids.

Anandamide Inhibition Of 5-Ht3a Receptors Varies With Receptor Density And Desensitization

Asymmetric Cross-Inhibition Between GABAA and Glycine Receptors in Rat Spinal Dorsal Horn Neurons.

Glycine Receptor Activation Regulates Short-Term Plasticity in CA1 Area of Hippocampal Slices of Rats.

N-methyl-D-aspartate Enhancement of the Glycine Response in the Rat Sacral Dorsal Commissural Neurons.

Exploring the Activation Process of the Glycine Receptor

Polymodal Activation of the Endocannabinoid System in the Extended Amygdala.

Differential Modulation of Nociceptive Versus Non-Nociceptive Synapses by Endocannabinoids.

Prediction of Essential Binding Domains for the Endocannabinoid N-Arachidonoylethanolamine (AEA) in the Brain Cannabinoid CB1 receptor

Endocannabinoid-mediated Potentiation of Nonnociceptive Synapses Contributes to Behavioral Sensitization.